dosis de tirzepatide Tablas Aplicación De Tirzepatida Tirzepatida? El fármaco más polémico
Description
Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors
#Type2Diabetes #CardiovascularRisk #Semaglutide #DiabetesCare #EvidenceBasedMedicine #NEJM #ClinicalPharmacy
Hear how GLP-1s actually perform in real-world populations and how they impact costs.
Learn what to avoid and how to stay safe.
